SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Oct-13 9:23 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 1,877 | -- | -- | (100%) 1.88K to 0 | |
03-Oct-13 4:38 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 1,877 | -- | -- | 100% 0 to 1.88K | |
06-Sep-13 4:02 PM View: | Watson Pharmaceuticals Inc. (ACT) | 04-Sep-13 | Market Sale | 6,064 | $139.54 | $846,163.00 | (76%) 7.94K to 1.88K | 83% |
14-May-13 1:36 PM View: | Watson Pharmaceuticals Inc. (ACT) | 10-May-13 | Grant | 1,877 | -- | -- | 31% 6.06K to 7.94K | |
08-Jun-12 3:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-Jun-12 | Option Exercise | 10,000 | $36.80 | $368,000.00 | 62% 16.06K to 26.06K | |
08-Jun-12 3:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-Jun-12 | Market Option Sale | 10,000 | $69.79 | $697,950.00 | (38%) 26.06K to 16.06K | 67% |
08-Jun-12 3:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-Jun-12 | Market Sale | 10,000 | $69.79 | $697,950.00 | (62%) 16.06K to 6.06K | 67% |
14-May-12 5:57 PM View: | Watson Pharmaceuticals Inc. (ACT) | 11-May-12 | Grant | 2,887 | -- | -- | 22% 13.18K to 16.06K | |
17-May-11 4:32 PM View: | Watson Pharmaceuticals Inc. (ACT) | 13-May-11 | Grant | 3,177 | -- | -- | 32% 10.0K to 13.18K | |
11-Mar-11 5:12 PM View: | Watson Pharmaceuticals Inc. (ACT) | 10-Mar-11 | Option Exercise | 20,000 | $36.80 | $736,000.00 | 133% 15.0K to 35.0K | |
11-Mar-11 5:12 PM View: | Watson Pharmaceuticals Inc. (ACT) | 10-Mar-11 | Market Option Sale | 20,000 | $56.42 | $1,128,400.00 | (57%) 35.0K to 15.0K | 60% |
11-Mar-11 5:12 PM View: | Watson Pharmaceuticals Inc. (ACT) | 10-Mar-11 | Market Sale | 5,000 | $56.42 | $282,100.00 | (33%) 15.0K to 10.0K | 60% |
09-Jun-10 6:25 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Jun-10 | Option Exercise | 17,000 | $28.19 | $479,230.00 | 85% 20.0K to 37.0K | |
09-Jun-10 6:25 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Jun-10 | Market Option Sale | 17,000 | $42.18 | $717,098.00 | (46%) 37.0K to 20.0K | 47% |
09-Jun-10 6:25 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Jun-10 | Market Sale | 5,001 | $42.18 | $210,953.00 | (25%) 20.0K to 15.0K | 47% |
11-May-10 4:21 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-May-10 | Grant | 5,000 | -- | -- | 33% 15.0K to 20.0K | |
11-May-09 4:36 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-May-09 | Grant | 5,000 | -- | -- | 50% 10.0K to 15.0K | |
12-May-08 4:59 PM View: | Watson Pharmaceuticals Inc. (ACT) | 09-May-08 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
07-May-07 7:32 PM View: | Watson Pharmaceuticals Inc. (ACT) | 04-May-07 | Grant | 3,334 | -- | -- | 200% 1.67K to 5.0K | |
09-May-06 10:38 AM View: | Watson Pharmaceuticals Inc. (ACT) | 05-May-06 | Grant | 1,667 | -- | -- | 100% 0 to 1.67K |